BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31710080)

  • 21. Association of XPG gene rs751402 polymorphism with gastric cancer risk: a meta-analysis in the Chinese population.
    Liang J; Xu YY; Zhang C; Xia QR
    Int J Biol Markers; 2018 May; 33(2):174-179. PubMed ID: 29148016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.
    Tavakolpour S
    Mult Scler Relat Disord; 2016 Jul; 8():66-73. PubMed ID: 27456877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The
    Das S; Naher L; Aka TD; Aziz MA; Shabnaz S; Shahriar M; Islam MS
    Heliyon; 2021 Jan; 7(1):e05919. PubMed ID: 33490679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to esophageal cancer in Chinese populations: a meta-analysis.
    Yang YB; Shang YH; Tan YL; Kang XJ; Meng M; Zhao ZX
    Asian Pac J Cancer Prev; 2014; 15(3):1345-9. PubMed ID: 24606463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals.
    Wang K; Liu L; Zhu ZM; Shao JH; Xin L
    Cytokine; 2011 Nov; 56(2):167-73. PubMed ID: 21798757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
    Yang M; Zou Y; Bai Y; Li M
    J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
    Dou K; Xu Q; Han X
    Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5,10-Methylenetetrahydrofolate reductase polymorphisms and colon cancer risk: a meta-analysis.
    Fang XY; Xu WD; Huang Q; Yang XK; Liu YY; Leng RX; Pan HF; Ye DQ
    Asian Pac J Cancer Prev; 2014; 15(19):8245-50. PubMed ID: 25339013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.
    Yang F; Mu X; Bian C; Zhang H; Yi T; Zhao X; Lin X
    J Cell Biochem; 2019 Sep; 120(9):15635-15647. PubMed ID: 31081240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between WRN Cys1367Arg (T>C) and Cancer Risk: A Meta-analysis.
    Wang B; Li G; Sun F; Dong N; Sun Z; Jiang D
    Technol Cancer Res Treat; 2016 Feb; 15(1):20-7. PubMed ID: 25468760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between three eNOS polymorphisms and cancer risk: a meta-analysis.
    Wu X; Wang ZF; Xu Y; Ren R; Heng BL; Su ZX
    Asian Pac J Cancer Prev; 2014; 15(13):5317-24. PubMed ID: 25040995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase-2 -1306 C>T gene polymorphism is associated with reduced risk of cancer: a meta-analysis.
    Haque S; Akhter N; Lohani M; Ali A; Mandal RK
    Asian Pac J Cancer Prev; 2015; 16(3):889-96. PubMed ID: 25735378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between HIF-1α C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies.
    Yan Q; Chen P; Wang S; Liu N; Zhao P; Gu A
    BMC Cancer; 2014 Dec; 14():950. PubMed ID: 25496056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.
    Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C
    Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
    Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
    Yi K; Yang L; Lan Z; Xi M
    Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.